“Highlighting 24 Renowned Cell Therapy Enterprises”
“Highlighting 24 Renowned Cell Therapy Enterprises”
The cell therapy industry encompasses firms focused on treating diseases at a cellular level. There, companies such as Terumo Blood and Cell Technologies and Bluebird Bio work to advance face of modern medicine by concentrating on biotechnology, ex-vivo gene therapy, and cell therapy manufacturing solutions. They cater to diverse yet specific medical needs ranging from blood supply to treatment of severe genetic diseases. Advancements in technology, research, and collaboration are shaping the future of the industry, where individualized treatments and precision medicine are likely to become more prevalent.
Top 24 Cell Therapy Companies
1. Terumo Blood and Cell Technologies
- Website: terumobct.com
- Headquarters: Lakewood, Colorado, United States
- Founded: 1964
- Headcount: 5001-10000
Terumo Blood and Cell Technologies is a company that specializes in cell therapy manufacturing solutions. They offer the Quantum Flex bioreactor platform, which enables cell therapy commercialization from process development through manufacturing. They collaborate with other organizations, such as GenCure and Eliaz Therapeutics, to advance cell and gene therapy treatments. Terumo Blood and Cell Technologies also supports Blood Emergency Readiness Corps to ensure an adequate blood supply in the United States.
2. bluebird bio
- Website: bluebirdbio.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 1993
- Headcount: 1001-5000
- Latest funding type: Post Ipo Equity
Bluebird is a biotechnology company founded in 2010, specializing in ex-vivo gene therapy. With a focus on severe genetic diseases, they have industry-leading programs for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy.
3. CRISPR Therapeutics
- Website: crisprtx.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2013
- Headcount: 201-500
- Latest funding type: Grant
CRISPR Therapeutics is a company that specializes in gene editing and cell therapies. They use the CRISPR/Cas9 therapeutic approach to treat genetically-defined diseases by editing cells inside the body.
4. Intellia Therapeutics, Inc.
- Website: intelliatx.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2014
- Headcount: 201-500
- Latest funding type: Post Ipo Equity
Intellia Therapeutics is a biotechnology company focused on developing CRISPR/Cas9 gene editing therapies. They are dedicated to transforming the lives of patients suffering from genetic diseases. Intellia Therapeutics is committed to using their expertise in genome editing to create innovative treatments.
5. Fate Therapeutics Inc
- Website: fatetherapeutics.com
- Headquarters: San Diego, California, United States
- Founded: 2007
- Headcount: 501-1000
Fate Therapeutics is a biotechnology company that specializes in immuno-oncology and immune disorders. They develop and manufacture cell-based therapies using induced pluripotent stem cells (iPSCs). With a mission to transform the lives of cancer patients, they offer candidates such as FT576 and FT819. The company focuses on research, development, and collaboration to advance their pipeline and bring innovative treatments to market.
6. ElevateBio
- Website: elevate.bio
- Headquarters: Waltham, Massachusetts, United States
- Founded: 2017
- Headcount: 201-500
- Latest funding type: Angel
Elevate.bio is a company that integrates cutting-edge technologies, end-to-end capabilities, and the smartest people to regenerate cells, rewrite genes, and redefine manufacturing. They provide next-generation enabling technologies in gene editing, induced pluripotent stem cells (iPSCs), and cell, protein, and vector engineering to equip partners with tools for potentially groundbreaking cell and gene therapies.
7. BlueRock Therapeutics
- Website: bluerocktx.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2016
- Headcount: 201-500
- Latest funding type: Acquired
BlueRock Therapeutics is a biotechnology company specializing in engineered cell therapy. They develop and provide innovative cell-based therapies for various diseases.
8. ACROBiosystems
- Website: acrobiosystems.com
- Headquarters: Newark, Delaware, United States
- Founded: 2010
- Headcount: 501-1000
- Latest funding type: Series Unknown
ACROBiosystems is a biotechnology company that specializes in providing high-quality target proteins, antibodies, and fusion proteins for immunization, antibody screening, and bispecific antibody development. They offer a wide range of products, including cytokines, growth factors, and therapeutic targets for various fields such as stem cell therapy and CAR-T cell therapy.
9. Precision BioSciences, Inc.
- Website: precisionbiosciences.com
- Headquarters: Durham, North Carolina, United States
- Founded: 2006
- Headcount: 201-500
- Latest funding type: Post Ipo Equity
Precision BioSciences is a company dedicated to in vivo gene editing therapies. They specialize in permanently correcting genetic diseases through their ARCUS platform and CAR T immunotherapy. Precision BioSciences collaborates with healthcare companies and researchers to develop potentially curative treatments. They offer expertise in precision medicine and have a strong skill set within the genome editing industry.
10. CBMG Holdings
- Website: cellbiomedgroup.com
- Headquarters: Rockville, Maryland, United States
- Founded: 2009
- Headcount: 201-500
- Latest funding type: Series A
Cellular Biomedicine Group, Inc. is a company that is focused on the development and commercialization of innovative cell-based therapeutics for the treatment of various diseases. They offer cutting-edge therapies that harness the power of stem cells to address unmet medical needs. With a strong commitment to scientific research and clinical development, the company aims to provide advanced and personalized treatment options for patients worldwide.
11. Celularity Inc.
- Website: celularity.com
- Headquarters: Florham Park, New Jersey, United States
- Founded: 2016
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Celularity is a clinical-stage biotechnology company specializing in the development of off-the-shelf placental-derived allogeneic cell therapies for cancer, immunologic, infectious, and degenerative diseases. They offer genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs).
12. Cellectis
- Website: cellectis.com
- Headquarters: Paris, Ile-De-France, France
- Founded: 1999
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Cellectis is a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells. They offer off-the-shelf immunotherapies that can work for a large number of patients.
13. SQZ Biotechnologies
- Website: sqzbiotech.com
- Headquarters: Watertown, Massachusetts, United States
- Founded: 2013
- Headcount: 51-200
- Latest funding type: Grant
SQZ Biotech is a company that specializes in cell therapies and regenerative medicine. They develop innovative technology called Cell Squeeze® Technology, which allows cells to transform into other cell types. SQZ Biotech offers a unique therapeutic candidate for HPV16+ solid tumors that activates CD8 T cells using a patient's own white blood cells and multiple mRNAs.
14. TreeFrog Therapeutics
- Website: treefrog.fr
- Headquarters: Pessac, Nouvelle-Aquitaine, France
- Founded: 2018
- Headcount: 51-200
- Latest funding type: Series B
TreeFrog Therapeutics is a cell therapy biotech based in Bordeaux, France. They develop allogeneic cell therapies based on human induced pluripotent stem cells (hiPSCs) and utilize their breakthrough technology – C-Stem™ – to scale-up cell therapy manufacturing in bioreactors. Their aim is to provide safe, efficient, and affordable cell therapies for all.
15. Ixaka
- Website: ixaka.com
- Headquarters: London, England, United Kingdom
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series Unknown
Ixaka is a cell and gene therapy company focused on utilizing the natural power of the body to cure a wide range of serious diseases. Their proprietary technologies, concentrated Multi-Cell Therapies (MCT) and Nano-Particle Therapeutics (NPT), have the potential to treat and even cure cancers, cardiovascular diseases, genetic disorders, neurological and ocular diseases.
16. PsiOxus
- Website: psioxus.com
- Headquarters: Abingdon, Oxfordshire, United Kingdom
- Founded: 2010
- Headcount: 51-200
PsiOxus Therapeutics is a clinical-stage company focused on redefining therapies for solid tumors with the potential to cure patients' cancer. They develop and deliver single or multi-protein therapeutics to tumors via an intravenously injected viral vector, reprogramming the tumor microenvironment and providing new treatment options for cancer patients.
17. Anocca AB
- Website: anocca.com
- Headquarters: Södertälje, Vasternorrlands Lan, Sweden
- Founded: 2014
- Headcount: 51-200
- Latest funding type: Debt Financing
Anocca is a privately funded biotech company based in Sweden. They specialize in developing next-generation immunotherapies that leverage the immune system of each patient. With a focus on engineered immunity, Anocca utilizes highly engineered human cellular, genetic, and molecular tools to develop and manufacture T-cell therapies and reagents for the treatment of cancer and infectious diseases.
18. Aspect Biosystems
- Website: aspectbiosystems.com
- Headquarters: Vancouver, British Columbia, Canada
- Founded: 2013
- Headcount: 51-200
- Latest funding type: Grant
Aspect Biosystems is a regenerative medicine company that utilizes a full-stack tissue therapeutic platform to create implantable tissues for treating disease and replacing damaged organ functions.
19. Universal Cells
- Website: universalcells.com
- Headquarters: Seattle, Washington, United States
- Founded: 2013
- Headcount: 11-50
- Latest funding type: Acquired
Universal Cells is a Seattle-based company that creates engineered, allogeneic stem cells which can be differentiated into various types of therapeutic cells. They edit genes required for immune recognition to produce universal donor, pluripotent stem cells using recombinant Adeno-Associated Virus (rAAV) gene editing technology. Their off-the-shelf, stem cell-based products are designed to cure diseases.
20. Curate Biosciences
- Website: curatebio.com
- Headquarters: Carlsbad, California, United States
- Founded: 2002
- Headcount: 11-50
Curate Bio is a company that specializes in transformative cell processing for next-generation therapies. They offer the Curate Cell Processing System, which dramatically improves the washing, separation, and concentration of apheresis products for advanced cell therapies. With their innovative technology, they deliver a substantially greater number of T cells at higher purities in dramatically less time.
21. Cell Therapies
- Website: celltherapies.com
- Headquarters: Melbourne, Victoria, Australia
- Founded: 2003
- Headcount: 51-200
Cell Therapies is an Australian-based contract development and manufacturing company specialized in cell and gene therapies with over 20 years of expertise in the clinical and commercialization of these products globally.
22. Flash Therapeutics
- Website: flashtherapeutics.com
- Headquarters: Toulouse, Occitanie, France
- Founded: 2018
- Headcount: 11-50
- Latest funding type: Debt Financing
Flash Therapeutics is a company that specializes in providing purified and highly concentrated particles for gene therapy. With their expertise in lentiviral vector manufacturing, they support projects from research to GMP grade production. They offer R&D and GMP manufacturing services and have partnered programs in regenerative medicine and cell therapy.
23. Miltenyi Biotec
- Website: miltenyibiotec.com
- Headquarters: Bergisch Gladbach, North Rhine-Westphalia, Germany
- Founded: 1989
- Headcount: 1001-5000
Miltenyi Biotec is a company specializing in the development and production of innovative solutions for biomedical research. They offer a wide range of products and services including stem cell enrichment, gene engineering, immune checkpoint analysis, antibodies, cytokines, and cell separation. Their technologies and tools are used by researchers and clinicians in various fields such as cancer research, immunotherapy, and cell therapy.
24. IsoPlexis
- Website: isoplexis.com
- Headquarters: Branford, Connecticut, United States
- Founded: 2013
- Headcount: 201-500
- Latest funding type: Acquired
IsoPlexis is a company that offers functional proteomics solutions for various research fields. Their innovative technologies enable the analysis of cellular and regenerative medicine, infectious diseases and vaccines, cancer immunology, inflammation and neurology. They provide cutting-edge instrumentation, software, and services to accelerate the understanding of immune response mechanisms and the development of potent therapies. With a focus on single-cell analysis, IsoPlexis aids researchers in uncovering new insights and advancing precision medicine.
Want to find more cell therapy companies?
If you want to find more companies that specialize in targeted treatments for genetic diseases and personalized biotechnology solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.
With Inven you'll also get to know the company's:
- Ownership: Which of these are private equity backed? Which are family-owned?
- Contact data: Who are the owners and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
